Thomas C. Dowling
Department of Pharmacy Practice and Science
School of Pharmacy
University of Maryland
Baltimore
USA
Name/email consistency: high
- Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Dowling, T.C., Matzke, G.R., Murphy, J.E., Burckart, G.J. Pharmacotherapy (2010)
- Disclosure and ethical conduct of clinical research. Dowling, T.C. Am. J. Health. Syst. Pharm (2008)
- Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Dowling, T.C. Am. J. Health. Syst. Pharm (2007)
- Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers. Dowling, T.C., Chavaillaz, P.A., Young, D.G., Melton-Celsa, A., O'Brien, A., Thuning-Roberson, C., Edelman, R., Tacket, C.O. Antimicrob. Agents Chemother. (2005)
- Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease. Dowling, T.C., Briglia, A.E., Fink, J.C., Hanes, D.S., Light, P.D., Stackiewicz, L., Karyekar, C.S., Eddington, N.D., Weir, M.R., Henrich, W.L. Clin. Pharmacol. Ther. (2003)









